Lin et al. reported that FLOT1 was markedly up-regulated in human breast cancer cells and tissues, and knock-down of FLOT1 inhibited the proliferation and tumorigenesis of breast cancer cells through the Akt/FOXO3a pathway [21]. The gene discussed is FOXO3; the disease is breast carcinoma.